Stocks
Jazz Pharmaceuticals plcJAZZ
NASDAQHealthcareBiotechnology$178.55-0.98%
Price as of · delayed, not real-time
A biopharmaceutical company focused on developing and commercializing innovative medicines for serious diseases, with a strong portfolio in sleep disorders and oncology. Investors track Jazz Pharmaceuticals for its specialty drug pipeline and recent acquisitions expanding its hematology/oncology footprint.
Market Cap: $11.0B52W Range: $95.49 – $198.00
Congressional Interest in Jazz Pharmaceuticals plc (JAZZ)
11 members of Congress have disclosed 14 trades in Jazz Pharmaceuticals plc (JAZZ), a Healthcare company. The buy/sell breakdown shows 6 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
14
Unique Politicians
11
Buys
6
Sells
8
Who in Congress Is Trading JAZZ?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-04-19 | SHELLEY BERKLEY | sell | 2,886.31 |
| 2023-07-12 | Daniel Goldman | sell | $15K – $50K |
| 2023-05-19 | Rohit Khanna | sell | $1K – $15K |
| 2023-03-06 | Daniel Goldman | buy | $15K – $50K |
| 2023-01-31 | Daniel Goldman | sell | $1K – $15K |
| 2021-10-19 | Thomas Suozzi | buy | $1K – $15K |
| 2019-07-15 | Bill Flores | buy | $15K – $50K |
| 2018-08-28 | Carlos Curbelo | buy | $1K – $15K |
| 2017-05-23 | MICHAEL T. MCCAUL | sell | $15K – $50K |
| 2015-05-27 | Thomas MacArthur | sell | $1K – $15K |
| 2015-01-09 | Tom Price | buy | $1K – $15K |
| 2012-11-12 | JIM COOPER | sell | $399,532 |
| 2012-09-03 | JIM COOPER | sell | $415,650 |
| 2009-05-08 | David P. Roe | buy | $100.00 |